Press release
Global Benign Prostatic Hyperplasia Devices Market Analysis 2026 Top companies are KARL STORZ SE & Co. KG, Olympus Corporation, Richard Wolf GmbH, Lumenis, Urologix, LLC, Boston Scientific Corporation
Global Benign Prostatic Hyperplasia Devices Market
Global Benign Prostatic Hyperplasia Devices Market By Procedure Type (Transurethral Resection of the Prostate (TURP), Prostatic Urethral Lift, Prostatectomy, Laser Surgery, Transurethral Microwave Therapy (TUMT), Transurethral Needle Ablation of the Prostate (TUNA), Prostatic Stenting/Implants, Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2026
Benign prostatic hyperplasia is also called as BPH which is a condition in men where the prostate gland is enlarged and is not cancerous. Benign prostatic hyperplasia is also known as benign prostatic obstruction or benign prostatic hypertrophy. The prostate usually goes through 2 main growth stages as a man ages. The first stage happens early in puberty, when prostate doubles in size, whereas the second phase of growth occurs around the age of 25 and continues through most of a man’s life. BPH often happens with the second stage of growth.
Download Free PDF Sample Copy of Report@ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-benign-prostatic-hyperplasia-devices-market
Global benign prostatic hyperplasia devices market is expected to reach at a CAGR of 12.2% in the forecast period of 2019 to 2026.
Competitive Analysis: Global Benign Prostatic Hyperplasia Devices Market
Some of the major players operating in this market are KARL STORZ SE & Co. KG, Olympus Corporation, Richard Wolf GmbH, Lumenis, Urologix, LLC,
Boston Scientific Corporation, Coloplast Corp, LISA Laser Products GmbH, Medifocus, Inc., Coloplast Corp, Teleflex Incorporated, Urotech Devices, BD, PROCEPT BioRobotics Corporation, Biolitec AG and others.
Market Developments:
In February 2019, Coloplast Corp, has signed a three-year group purchasing agreement for general urological products with Premier, Inc. (U.S.). This agreement helps the company in distributing their products by Premier, Inc. This will help in further expansion of the market.
In January 2019, Richard Wolf GmbH presented the innovative system solutions at ARAB HEALTH from 28th January to 31st January for minimally invasive human medicines. This would help in enhancing the customer base of the company.
In November 2018, Teleflex Incorporated’s subsidiary Neotract, Inc. (U.S.) received clearance from the Ministry of Health, Labor and Welfare (MHLW) in Japan. This regulatory approval will act as a landmark for NeoTract, as this will permit the UroLift system as an alternative to physicians who treats BPH in Japan. This will offer the company to generate more revenue.
In November 2018, Olympus Corporation announced its investment in the Israeli based company with Medi-Tate Ltd., a manufacturer of minimally invasive benign prostatic hyperplasia devices. This investment allowed the company to strengthen its support in the urology with expanded options in the enhanced patient care along with complementary offerings to the robust BPH portfolio.
In November 2018, Karl Storz installed a hybrid operating room at Tungs Taichung MetroHarbor Hospital in Taiwan. This can be used as a room for minimally invasive surgery, one for robotic surgery and ORs for critical and acute care. This strategy would help in enhancing the customer base of the company.
In September 2018, Boston Scientific acquired a privately-held company Augmenix, Inc. (U.S.). Augmenix, Inc. has developed a specially designed system SpaceOAR System for the therapy used to ease common and unbearable side effects of prostate cancer radiotherapy. The acquisition will strengthen the company’s market positioning and the SpaceOAR hydrogel is a vital addition the prostate health treatment products.
In June 2018, PROCEPT BioRobotics Corporation was awarded with the “Best Healthcare Robotics Solution”, award by MedTech Breakthrough. This is an independent organization which identifies the top technologies, products and companies in the global health and medical technology market. This would help in enhancing the customer base of the company.
In March 2017, Lumenis showcased its Moses Technology at European Association of Urology Annual Congress. The Moses technology is specially designed to ease retropulsion in lithotripsy procedure. This will help ingrasping more number of customers and will also help in creating a new customer
base.
In February 2017, Medical Technology organization Richard Wolf took first place in OR reconciliation arrangement center nova in Category B “IT and Communication” at the Management and Hospital AWARD 2017. This award benefitted the company to build its reputation in the market amongst other medical companies.
Market Trends:
Global benign prostatic hyperplasia devices market is segmented based on procedure type, end user.
On the basis of procedure type, the market is segmented into transurethral resection of the prostate (TURP), prostatic urethral lift, prostatectomy, laser surgery, transurethral microwave therapy (TUMT), transurethral needle ablation of the prostate (TUNA), prostatic stenting/implants and others. Laser surgery is sub-segmented into holmium lasers, green light laser/PVP and thulium laser based devices. The others segment is sub-segmented into water-induced thermotherapy, high-intensity frequency ultrasound (HIFU), prostatic artery embolization (PAE) and others. In 2019, transurethral resection of the prostate (TURP) segment is projected to lead with 25.1% market shares, whereas prostatic urethral lift segment will attend the highest CAGR of 13.1% in the forecast period of 2019 to 2026.
Inquire about this report from our expert’s @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-benign-prostatic-hyperplasia-devices-market
On the basis of end user, the market is segmented into hospitals and clinics and ambulatory surgical centers. In 2019, hospitals and clinics segment is projected to lead with 77.9% market shares and will attend the highest CAGR of 12.5% in the forecast period of 2019 to 2026.
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Benign Prostatic Hyperplasia Devices Market Analysis 2026 Top companies are KARL STORZ SE & Co. KG, Olympus Corporation, Richard Wolf GmbH, Lumenis, Urologix, LLC, Boston Scientific Corporation here
News-ID: 1694922 • Views: …
More Releases from Data Bridge Market Research
Vitamin K Market IS growing at a CAGR of 6.8% during the forecast period of 2023 …
Vitamin K Market Analysis and Size
The essential factors contributing to the growth of the market in the forecast period of 2023 to 2020 include growing demand for vitamin supplements, changing dietary patterns, and rising health consciousness.
Data Bridge Market Research analyses that the global vitamin K market, which was USD 841.47 million in 2022, is expected to reach USD 1,410.20 million by 2030, growing at a CAGR of 6.8% during the…
Transformer Oil Market is expected to undergo a CAGR of 7.55% by 2029
Transformer Oil Market Analysis and Size
Transformers are almost everywhere, and every power and distribution transformer is filled with the dielectric insulating fluid, which consists high resistance to electricity and cools the transformer. The "bio based oil" is the highest growing type segment because it has better resistance to fire as compared to other oil over the forecast period. Furthermore, the growth of electric grids in developing economies and the upgradation…
Fatty Alcohols Market is expected to undergo a CAGR of 5.15% by 2029
Fatty Alcohols Market Analysis and Size
The rising demand of hygiene product coupled with growing consumer awareness is anticipated to drive the personal care industry and boost the growth of the fatty alcohols market. Fatty alcohols are used as emollients, emulsifiers and catalytic hydrogenation in cosmetics and beauty products. The "C11-C14 fatty alcohols" is the fastest growing product segment because it is used to produce sodium laureth ether sulphate (SLES), a major foaming agent…
Exclusive Insights on Gusseted Bags Market Latest Trends, Drivers, Strategies an …
An important Gusseted Bags Market research report is produced by taking into account every requirement that organizations need to meet in order to expand successfully. This market report forecasts the market size based on data on major retailer sales, industry growth by upstream and downstream factors, industry advancement, major players, market segments, and application. When creating the reliable Gusseted Bags Market study, the goals of the marketing research are taken into…
More Releases for Benign
Benign Prostatic Hyperplasia Therapeutics Market Clinical Survey Report 2020
The Benign Prostatic Hyperplasia Therapeutics Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Click the link…
Benign prostatic hyperplasia: BPH drugs versus Dr Allen’s Device
The Global Treatment Market of Benign prostatic hyperplasia (BPH) was valued at $10,688.72 million in 2017 and is projected to reach $20,096.68 million by 2025 at a CAGR of 8.1% from 2018 to 2025.
Thermobalancing therapy with Dr Allen’s Device was patented by the United States Patent and Trademark Office. Over a decade, thousands of men with BPH used or are using this non-invasive and side-effects free Dr Allen’s Device.…
Cold Plasma Market Benign Rate by 2025
Global Cold Plasma Market: Snapshot
Cold plasma, additionally called non-warm plasma or non-balance plasma, is a sort of plasma—ordinarily known as the fourth condition of issue—which has gas particles show at direct temperature and electrons at moderately high temperatures. The properties of plasma have been widely looked into in the course of recent decades and an extensive number of front line utilizations of cold plasma innovation has exuded.
Cold plasma isn't in…
Benign Prostatic Hyperplasia Therapeutics Market Epidemiology Analysis, Therapy, …
The global benign prostatic hyperplasia therapeutics market is expected to witness significant growth, as increased number of effective treatments are available for cancer. Increasing awareness regarding various cancer treatment drugs, technological advancements, and growing demand for safe and effective medications are acting as the major growth drivers for the benign prostatic hyperplasia therapeutics market. Globally, regulatory bodies are adding to the growth of the market with provision of funding, grants…
Benign Prostatic Hyperplasia and Prostatitis Devicebased Treatments Market
ReportsWorldwide has announced the addition of a new report title Benign Prostatic Hyperplasia and Prostatitis Devicebased Treatments Market to its growing collection of premium market research reports.
This analysis includes a discussion of products, competitors, market forecasts, and opportunities in the global market for BPH and prostatitis treatment devices.
Topics Covered Include:
An overview of device-based and pharmacological therapies for BPH and prostatitis.
Global and country/region-specific market forecasts, including forecasts by product segment.
Competitive analyses…
Benign Prostatic Hyperplasia Therapeutics Development Pipeline Overview for H1 2 …
2017 Benign Prostatic Hyperplasia pipeline market report of on global industry analysis and opportunity assessment H1 report provides comprehensive information on the therapeutics under development for Benign Prostatic Hyperplasia (Male Health), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.
Get Discount on this Research Report at http://www.reportsnreports.com/contacts/discount.aspx?name=1010746
Benign Prostatic Hyperplasia (BPH) is a non-cancerous enlargement of the prostate, a…
